China's First Commercial BCI Is a Wake-Up Call for the Brain-as-Computer Era

Sun, 05 Apr 2026 00:00:00 +0000

On March 13, 2026, China’s National Medical Products Administration granted the world’s first commercial approval for an invasive brain-computer interface. The device is called NEO — a coin-sized wireless implant developed by Shanghai-based Neuracle Medical Technology in collaboration with Tsinghua University, placed epidurally on the brain’s outer membrane. When a patient imagines moving their hand, NEO reads the motor cortex signal and wirelessly drives a soft robotic glove to grasp, hold, and manipulate objects. Target users: adults aged 18–60 with partial paralysis from cervical spinal cord injuries.

This is not a clinical trial. NEO is a commercial medical product — cleared for sale, surgical implantation, and real-world clinical use in Chinese hospitals today.

In one regulatory stroke, BCIs moved from experimental labs into everyday medicine. The brain-as-computer era has officially begun — and China fired the starting gun.

NEO Implant on BIOCOMPUTER

China's First Commercial BCI Is a Wake-Up Call for the Brain-as-Computer Era